References
Amiel S. A., Sherwin R. S., Simonson D. C., Lauritano A. A., Tamborlane W. V.: Impaired insulin action in puberty: a contributor to poor diabetic control during adolescence — New Engl. J. Med.315, 215–219, 1986.
Andersen A. R., Christiansen J. S., Andersen J. K., Kreiner S., Deckert T.: Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study — Diabetologia25, 496–501, 1983.
Ballard D. J., Humphrey L. L., Melton L. J. III, Frohnert P. P., Chu C.-P., O’Fallon W. M., Palumbo P. J.: Epidemiology of persistent proteinuria in type 2 diabetes mellitus. Population based study in Rochester, Minnesota — Diabetes37, 405–412, 1988.
Bjorck S., Nyberg G., Mulec H., Granerus G., Herlitz H., Aurell M.: Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy — Brit. med. J.293, 471–474, 1986.
Borch-Johnsen K., Andersen P. K., Deckert T.: The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus — Diabetologia28, 590–596, 1985.
Borch-Johnsen K., Kreiner S.: Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes — Brit. med. J.294, 1651–1654, 1987.
Bunker C. H., Mallinger A. G.: Sodium-lithium countertransport, obesity, insulin, and blood pressure in healthy premenopausal women — Circulation72 (Suppl. III), 296, 1985.
Cameron J. S., Challah S.: Treatment of end-stage renal failure due to diabetes in the United Kingdom 1975–1984 — Lancetii, 962–966, 1986.
Chavers B. M., Bilous R. W., Ellis E. N., Steffes M. W., Mauer S. M.: Clomerular lesions and urinary albumin excretion in Type I diabetes without overt proteinuria — New Engl. J. Med.320, 966–970, 1989.
Close C. F., on Behalf of the MCS Group: Sex, diabetes duration and microalbuminuria in type 1 (insulin-dependent) diabetes mellitus — Diabetologia30, 508A, 1987.
Feldt-Rasmussen B.: Increased transcapillary escape rate of albumin in type 1 (insulin-dependent) diabetic patients with microalbuminuria — Diabetologia29, 282–286, 1986.
Ferrannini E., Buzzigoli G., Bonadonna R., Giorico M. A., Oleggini M., Graziadei L., Pedrinelli R., Brandi L., Bevilacqua S.: Insulin resistance in essential hypertension — New Engl. J. Med.317, 350–357, 1987.
Foster D. W.: Insulin resistance. A secret killer — New Engl. J. Med.320, 733–734, 1989.
Gatling W., Knight C., Mullee M. A., Hill R. D.: Microalbuminuria in diabetes: a population study of the prevalence and an assessment of three screening tests — Diabet. Med.5, 343–347, 1988.
Hasstedt S. J., Wu L. L., Ash K. O., Kuida H., Williams R. R.: Hypertension and sodiumlithium countertransport in Utah pedigrees. Evidence for major locus inheritance — Amer. J. hum. Genet.43, 14–22, 1988.
Jensen T., Borch-Johnsen K., Kofoed-Enevoldsen A., Deckert T.: Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors — Diabetologia30, 144–148, 1987.
Jensen R., Stender S., Deckert T.: Abnormalities in plasma concentrations of lipoprotein and fibrinogen in Type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion — Diabetologia31, 142–145, 1988.
Jones S. L., Close C. E., Mattock M. B., Jarrett R. J., Keen H., Viberti G. C.: Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria — Brit. med. J.289, 487–490, 1989.
Jones S., Trevisan R., Tariq T., Semplicini A., Mattock M., Walker J. D., Nosadini R., Viberti G. C.: Sodium-lithium countertransport in microalbuminuric insulin-dependent diabetic patients — Hypertension15, 570–575, 1990.
Khanna R., Wu G., Chisholm L., Oreopoulos D. G.: Further experiences with CAPD in diabetics with end-stage renal disease — Diabet. Nephr.2, 8–12, 1983.
Knowler W. C., Kunzelman C. L.: Population comparisons of the frequency of diabetic nephropathy. In:Mogensen C. E. (Ed.): The Kidney and Hypertension in Diabetes Mellitus. Martinus Nijhoff Publ., Boston/MA, 1988; pp. 25–32.
Krolewski A. S., Canessa M., Warram J. H., Laffel L. M. B., Christlieb A. R., Knowler W. C., Rano L. I.: Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus — New Engl. J. Med.318, 140–145, 1988.
Krolewski A. S., Warram J. H., Christlieb A. R., Busick E. J., Kahn C. R.: The changing natural history of nephropathy in type 1 diabetes — Amer. J. Med.78, 785–794, 1985.
Lervang H. H., Jensen S., Brochner-Mortensen J., Ditzel J.: Early glomerular hyperfiltration and the development of late nephropathy in type 1 (insulin-dependent) diabetes mellitus — Diabetologia31, 723–729, 1988.
Mahnensmith R. L., Aronson P. S.: The plasma membrane sodium-hydrogen exchanger and its role in physiological and pathophysiological processes — Circulat. Res.56, 773–778S, 1985.
Mangili R., Bending J. J., Scott G., Li L. K., Gupta A., Viberti G. C.: Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy — New Engl. J. Med.318, 146–150, 1988.
Marshall S. M., Alberti K. G. M. M.: Comparison of the prevalence and associated features of abnormal albumin excretion in insulin-dependent and non-insulin-dependent diabetes — Quart. J. Med.261, 61–71, 1989.
Mathiesen E. R., Oxenboll B., Johansen K., Svendsen P. Aa., Deckert T.: Incipient nephropathy in type 1 (insulin-dependent) diabetes — Diabetologia26, 406–410, 1984.
Microalbuminuria Collaborative Study Group, UK: Microalbuminuria and glycaemic control. In: Diabetic Complications 87. Multicentre and/or Prospective Study Session on Diabetic Complications. Consiglio Nazionale delle Ricerche, Rome, 1987.
Mogensen C. E.: Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment — Scand. J. clin. Lab. Invest.36, 383–388, 1976.
Mogensen C. E., Christensen C. K.: Predicting diabetic nephropathy in insulin-dependent diabetic patients — New Engl. J. Med.311, 89–93, 1984.
Moorhead J. F., Chan M. K., El-Nahas M., Varghese Z.: Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease — Lancetii, 1309–1311, 1982.
Nosadini R., Viberti G. C., Doria A., Fioretto P., Trevisan R., Avogaro A., Semplicini A., Donadon V., Zanetta G., Luisiani G.: Increased Na+/Li+ countertransport activity is associated with cardiac hypertrophy and insulin resistance in hypertensive Type I (insulin-dependent) diabetics — Diabetologia32, 523A, 1989; Abstract.
Oakley W. G., Pyke D. A., Tattersal R. B., Watkins P. J.: Long term diabetes: a clinical study of 92 patients after 40 years — Quart. J. Med.43, 145–156, 1984.
Parving H. H., Andersen A. R., Smidt U. M., Hommel E., Mathiesen E. R., Svendsen P. Aa.: Effect of antihypertensive treatment on kidney function in diabetic nephropathy — Brit. med. J.294, 1443–1447, 1987.
Parving H. H., Hommel E., Mathiesen E. R.: Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin-dependent diabetes — Brit. med. J.296, 156–160, 1988.
Sampson M. J., Chambers J., Spriggins D., Drury P. L.: Echocardiographic evidence of relative left ventricular hypertrophy in Type 1 (insulin-dependent) diabetic patients with microalbuminuria — Diabetologia32, 539A, 1988.
Seaquist E. R., Goetz F. C., Rich S., Barbosa J.: Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy — New Engl. J. Med.320, 1161–1165, 1989.
Sieberberg J. S., Barre P. E., Pritchard S. S., Snidrman A. D.: Impact of left ventricular hypertrophy on survival in end-stage renal disease — Kidney Intern.36, 286–290, 1989.
Taguma Y., Kitamoto Y., Futaki G., Monna H., Ishizaki M., Takahashi H., Veda H., Sekino H., Sasaki Y.: Effect of captopril on heavy proteinuria in azotemic diabetics — New Engl. J. Med.313, 1617–1620, 1985.
Trevisan R., Li L. K., Walker J. D., Viberti G. C.: Overactivity of Na+/H+ antiport and enhanced cell growth of Type 1 (insulin-dependent) diabetics with nephropathy — Diabetologia32, 549A, 1989.
Vannini P., Ciavarella A., Flammini M., Bargossi A. M., Forlani G., Borgnino L. C., Orsoni G.: Lipid abnormalities in insulin-dependent diabetic patients with albuminuria — Diabet. Care7, 151–154, 1984.
Viberti G. C., Bilous R. W., Mackintosh D., Bending J. J., Keen H.: Long term correction of hyperglycaemia and progression of renal failure in insulin-dependent diabetes — Brit. med. J.286, 598–602, 1983.
Viberti G. C., Bilous R. W., Mackintosh D., Keen H.: Monitoring glomerular function in diabetic nephropathy — Amer. J. Med.74, 256–264, 1983.
Viberti G. C., Hill R. D., Jarrett R. J., Argyrropoulos A., Mahmud U., Keen H.: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus — Lanceti, 1430–1432, 1982.
Viberti G. C., Keen H.: The patterns of proteinuria in diabetes mellitus — Diabetes36, 556–565, 1987.
Viberti G. C., Keen H., Dodds R. A., Bending J. J.: Metabolic control and progression of diabetic nephropathy — Diabetologia30, 481–482, 1987.
Viberti G. C., Keen H., Wiseman M. J.: Raised arterial pressure in parents of proteinuric insulin-dependent patients — Brit. med. J.295, 575–577, 1987.
Viberti G. C., Wiseman M. J.: The kidney in diabetes. Significance of the early abnormalities — Clin. Endocrinol. Metabol.15, 753–782, 1986.
Walker J. D., Bending J. J., Dodds R. A.: Restriction of dietary protein and progression of renal failure in diabetic nephropathy — Lancetii, 1411–1414, 1989.
Williams R. R., Hunt S. C., Wu L. L., Hasstedt S. J., Hopkins P. N., Ash K. O.: Genetic and epidemiological studies on electrolyte transport systems in hypertension — Clin. Physiol. Biochem.6, 136–149, 1988.
Wiseman M. J., Viberti G. C., Mackintosh D., Jarrett R. J., Keen H.: Glycaemia, arterial pressure and microalbuminuria in Type 1 (insulin-dependent) diabetes mellitus — Diabetologia26, 402–405, 1984.
Zatz R., Meyer T. M., Rennke H. G., Brenner B. M.: Predominance of haemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy — Proc. nat. Acad. Sci. (Wash.)82, 5963–5967, 1985.
Zavaroni I., Bonora E., Pagliara M., Dall’Aglio E., Luchetti L., Buonanno G., Bonati P. A., Bergonzani M., Gnudi L., Passeri M., Reaven G.: Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance — New Engl. J. Med.320, 702–706, 1989.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Viberti, G.C. Mechanisms of diabetic renal and cardiovascular disease. Acta diabet. lat 27, 267–276 (1990). https://doi.org/10.1007/BF02581339
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02581339